Stay updated on Olezarsen in Hypertriglyceridemia and CVD Clinical Trial
Sign up to get notified when there's something new on the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page.

Latest updates to the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new Revision: v3.3.3 is added, and HHS Vulnerability Disclosure and Revision: v3.3.2 are removed from the page history.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry (v3.3.2) was added and an earlier revision (v3.2.0) removed, reflecting page versioning rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe government funding notice banner on the Record History page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check58 days agoChange DetectedThe changes are minor visual and labeling adjustments to the Record History page with no core trial data or status changes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference11%

- Check94 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Olezarsen in Hypertriglyceridemia and CVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page.